Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. - Wikidata - wikimedia - TriplyDB

Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography.

Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography.

http://www.wikidata.org/entity/Q30433929

about

Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future Directions.Prediction of liver cirrhosis, using diagnostic imaging tools.Magnetic resonance elastography of abdomen.Ultrasound Elastography and MR Elastography for Assessing Liver Fibrosis: Part 1, Principles and Techniques.Noninvasive Assessment of Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease.Magnetic resonance elastography is accurate in detecting advanced fibrosis in autoimmune hepatitis Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease: A prospective study.Non-invasive screening of diabetics in primary care for NAFLD and advanced fibrosis by MRI and MRE.Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study.Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease Comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease: a prospective study.Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data.Non-Invasive Evaluation of Hepatic Fibrosis: The Diagnostic Performance of Magnetic Resonance Elastography in Patients with Viral Hepatitis B or C Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)Non-invasive methods for the diagnosis of nonalcoholic fatty liver disease Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.Three-Tesla magnetic resonance elastography for hepatic fibrosis: comparison with diffusion-weighted imaging and gadoxetic acid-enhanced magnetic resonance imaging.NIH workshop on clinical translation of molecular imaging probes and technology--meeting report.Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.Magnetic resonance elastography of liver: clinical applications.Noninvasive diagnosis of cirrhosis: a review of different imaging modalities.Noninvasive assessment of hepatic fibrosis in patients with chronic hepatitis B viral infection using magnetic resonance elastography.Identifying nonalcoholic fatty liver disease patients with active fibrosis by measuring extracellular matrix remodeling rates in tissue and blood.Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.Noninvasive evaluation of NAFLD.Hepatic steatosis and steatohepatitis: Are they really two distinct entities?Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives.Pattern and profile of chronic liver disease in acute on chronic liver failure.Liver Fibrosis Quantification by Magnetic Resonance Imaging.Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis.Magnetic Resonance Elastography to Assess Fibrosis in Kidney Allografts.The Diagnosis and Management of Nonalcoholic Fatty Liver Disease: Practice Guidance from the American Association for the Study of Liver Diseases.

P2860

Q26738871-907DF2E8-0C48-467D-BAC5-7F84C574F748 Q26795413-62C89F0B-AD53-4136-BAB5-2E4CB797D404 Q26852613-3938A9B2-16D1-42CC-AD3C-5178E8BC9012 Q28081275-381AD0E3-79D6-4077-A5FF-9F810ED442F7 Q28082686-44885396-7AF3-4987-94C8-506DEAE3F7D5 Q30355082-9E0B8665-2A69-44F2-BEAD-B96D7062D727 Q30362976-FFADE982-C3C9-455D-B609-6C3C74663AE3 Q30364476-2C758F99-6AAA-4237-971C-B6B70B4141B9 Q30366569-CECF898C-AE38-4734-9800-13E13A6AEC50 Q30366572-84042E95-3297-4552-8A68-ACF39F53C842 Q30368624-38D4DAD8-81FF-444D-BC8C-6DE72EDB907C Q30372813-7B013A9D-5B20-4C2F-AFF7-7B619EB62D9A Q30376231-4718E4F0-4631-4556-B0D8-16474A138B3B Q30382172-06FF52D6-FA76-40DF-8371-46A86154E453 Q30389544-2987C417-BB38-4007-A744-FADF0AC3CD4A Q30400175-8F9CE30A-740F-4940-9333-CC73ED695AC2 Q30413592-06349A52-A3D5-44DC-BCE8-25741C5F4AFA Q30414504-00BB0403-C1C0-47C4-ABF4-EFF71A46D5CF Q30418856-49B73B8C-9169-4813-A129-9400B41EA48F Q30422941-CFBF2C5F-055C-4DC2-BA02-9A30673F4476 Q30430958-BBCC7DE5-9160-44FE-9B16-70239318EE17 Q30432576-B1A01320-8078-4055-818C-BA71633C713E Q30435917-F1A1527F-218E-4FF1-BAA0-635D9B5EA4AE Q30436164-AE46D75B-855E-4706-BA43-467A2DC8A28D Q30441644-8DBCDDAA-3B27-41E4-861E-D09648CFDA5C Q31134971-22762184-DC43-447F-AF44-71C4BBE6D334 Q35664034-EA952614-3064-43D9-A6D0-6A000036C9B9 Q36156172-2553FC65-38A9-40EC-BFBF-9B1E13FB2188 Q36359100-AA849FCF-AA21-4189-9E63-321AD9E812AD Q37373282-A917CE57-8E43-48C3-AC1F-E0EC264D53B7 Q37488800-056BDD1A-E5DC-4C02-9F65-3ACDD0DA212B Q38141711-355ECE83-4FD0-489F-A00E-AE11E77C3ED1 Q38224490-D68E549B-687D-4E80-8028-BE5841E794AE Q38397177-EB49EF94-14B3-48A4-8146-276950DC3223 Q38494198-4B67707C-C3F6-4E1E-8B1F-4A26DDD0A8C1 Q38504279-1345185A-31B8-4741-9261-8E9A8E543C1F Q38600259-CC1A35CB-1410-4539-B44F-1F1AF2F067BE Q38607766-CC39E519-F6D0-4236-8A06-348A70AC335B Q38635428-F7541491-8EEB-44C2-A34B-874DE8D41F87 Q38676257-3480423B-9773-4FDC-BA5C-12FD1E5E8FAD

P2860

Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography.

http://www.wikidata.org/entity/Q30433929

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Advanced fibrosis in nonalcoho ...... sessment with MR elastography.

@ast

Advanced fibrosis in nonalcoho ...... sessment with MR elastography.

@en

type

label

Advanced fibrosis in nonalcoho ...... sessment with MR elastography.

@ast

Advanced fibrosis in nonalcoho ...... sessment with MR elastography.

@en

prefLabel

Advanced fibrosis in nonalcoho ...... sessment with MR elastography.

@ast

Advanced fibrosis in nonalcoho ...... sessment with MR elastography.

@en

P1433

Q30433929-0A91E8C5-818D-49B3-8B89-C8023CADC977

P1476

Q30433929-8EC8F324-5D67-4C52-AFD5-E76BDAF70D23

P2093

Q30433929-1850370A-DB1F-4803-BFA0-9981EFDB0CDD

Q30433929-A60209BB-8E01-4E69-91BB-87191360F086

Q30433929-A929CCA3-9944-4761-AD54-2F4C928EA28B

Q30433929-EA00E7C2-E273-44A1-9150-8038241AF849

Q30433929-EBADCD09-CFE5-4637-8706-767A72657F8A

P2860

Q30433929-04F532F6-A5DC-4173-B5D2-F840424D96A3

Q30433929-06221CA4-AD98-48D0-9B26-E2D3BEDCE4A8

Q30433929-0D70FA9E-4D46-46BC-AB5E-293694698286

Q30433929-13610D4C-D739-4136-ABB4-A75527B452B0

Q30433929-143ADC33-108C-4285-902C-54238B92B56B

Q30433929-2C4A515A-F13B-41AC-8949-D236D157AB3B

Q30433929-416DFE5B-0EA0-4544-A8A6-72D444FAE82F

Q30433929-4ED350FA-F24F-43F1-8BD2-F87BFE542A37

Q30433929-50FE4133-93EE-45F4-9711-F94228902B55

Q30433929-578C45EA-6179-458B-A223-88BCC809C578

P304

Q30433929-4A1A9E1E-FE1B-4665-AF65-F108E2FC7C13

P31

Q30433929-AF681D88-481C-4674-B856-7D29EA689EC4

P356

Q30433929-F01124B3-A943-416B-BCB8-D745777C072D

P407

Q30433929-783CD6E1-5EC5-45E8-A26B-9F8DD1F08F43

P433

Q30433929-FB6367E9-1164-4066-B995-114D714B831C

P478

Q30433929-2059D176-71AB-4007-B656-E3990CACFF94

P577

Q30433929-2EBC403D-ED6E-4C14-A088-D04F4BB4FAA6

P5875

Q30433929-D8ACE9AD-C3E6-4AA9-822B-CFEE5C211CB8

P698

Q30433929-6B09BD91-5977-43FC-9245-6B53CB75A817

P932

Q30433929-770653B4-8B30-4E70-AAB7-E88ABC2E8FFA

P356

RADIOL.13121193

P1433

P1476

Advanced fibrosis in nonalcoho ...... sessment with MR elastography.

@en

P2093

Donghee Kim

http://www.w3.org/2001/XMLSchema#string

Hwa Jung Kim

http://www.w3.org/2001/XMLSchema#string

Jayant A Talwalkar

http://www.w3.org/2001/XMLSchema#string

Richard L Ehman

http://www.w3.org/2001/XMLSchema#string

W Ray Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

Magnetic resonance elastography by direct visualization of propagating acoustic strain waves

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C

Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography.

Repeatability of magnetic resonance elastography for quantification of hepatic stiffness.

Cross-validation of magnetic resonance elastography and ultrasound-based transient elastography: a preliminary phantom study.

P304

411-419

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.13121193

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

268

http://www.w3.org/2001/XMLSchema#string

P577

2013-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236129352

http://www.w3.org/2001/XMLSchema#string

P698

23564711

http://www.w3.org/2001/XMLSchema#string

P932

3721049

http://www.w3.org/2001/XMLSchema#string